Retrovirus infection and retinoid
スポンサーリンク
概要
- 論文の詳細を見る
Human T -cell leukemia virus type I (HTLV-I) is a human retrovirus and an etiologic agent of adult T-cell leukemia/lymphoma (ATL/ATLL). The subtypes acute and lymphoma have a poor prognosis with a median survival rate of approximately 6 months. Some excellent therapeutic strategies for ATL are required. In present study, we show effects of a new therapeutic agent, retinoid, for proliferation, CD25 expression, NFκ-B transcription activity, influence of thiol compound. Furthermore, we clarified a mechanism of retinoid for ATL cells. Finally, we showed an evaluation of retinoid therapy in clinical including for skin involvement.
論文 | ランダム
- 南大洋における降雪の酸素安定同位体比の緯度分布と季節変化
- Supply Chain Management in the Paper & Pulp Industry
- 有料放送顧客におけるコンテンツ消費行動に関する研究～コンテンツ消費と情報処理型消費者行動モデル～
- 重イオンビームを用いた基礎・応用研究
- 周術期感染性合併症が消化器癌術後の予後に与える影響